Suzano secures antitrust clearances for Kimberly-Clark tissue assets deal

Kimberly-Clark Corporation

Kimberly-Clark Corporation

KMB

0.00
  • All antitrust clearances have been secured for Suzano International Holding’s purchase of 51% of a Netherlands-based tissue products venture from Kimberly-Clark.
  • Closing still hinges on Kimberly-Clark completing a corporate reorganization across multiple regions; timing remains targeted for Q3 2026.
  • The venture will house tissue manufacturing and sales assets across included regions, while Kimberly-Clark retains 49% and keeps North America tissue assets.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Suzano SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-038610), on May 28, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.